Table 3 Criteria for defining clinical inactive disease in oligoarticular (persistent and extended), polyarticular (RF+ and -), and systemic JIA*
From: Clinical outcome measures in juvenile idiopathic arthritis
Inactive disease |
|---|
- No joints with active arthritis |
- No fever, rash, serositis, splenomegaly, or generalized lymphadenopathy attributable to JIA |
- No active uveitis as defined by the SUN Working Group [28] |
- ESR or CRP level within normal limits in the laboratory where tested or, if elevated, not attributable to JIA |
- Physician’s global assessment of disease activity score of best possible on the scale used |
- Duration of morning stiffness of 15Â min |